Absorption, Distribution, Metabolism And Excretion Study For GSK221149A

NCT00457925 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline